- Home
- RNAC vs JONE Comparison
RNAC vs JONE Comparison
Compare RNAC & JONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | JONE |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 281.9M |
| IPO Year | 2016 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RNAC | JONE |
|---|---|---|
| Price | $7.62 | N/A |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | |
| Target Price | $34.00 | N/A |
| AVG Volume (30 Days) | 94.2K | N/A |
| Earning Date | 05-11-2026 | 09-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.60 | N/A |
| 52 Week High | $11.00 | N/A |
Technical Indicators
Market Signals| Indicator | RNAC | JONE |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 57.90 |
| Support Level | $5.88 | N/A |
| Resistance Level | $8.39 | $9.86 |
| Average True Range (ATR) | 0.42 | 0.03 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 12.65 | 42.11 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About JONE Jones Ventures INTL Acquisition1 Corp Class A Ordinary Shares
Jones Ventures INTL Acquisition1 Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.